2024 Annual Conference

Basal Cell and Squamous Cell Skin Cancers: NCCN Guidelines® Updates Based on Risk Status

Objectives

• Identify characteristics of each patient risk status classification for squamous and basal cell skin cancer.
• Review treatment options for each patient subset.
• Compare and contrast emerging regimen options and assess which patients can benefit from these therapies.

Updates to the Management of Cutaneous Melanoma

Objectives

• Identify patients that can benefit from neoadjuvant therapy for melanoma.
• Compare and contrast treatment options for late-stage melanoma to optimize patient outcomes.

Updates to the Management of Endometrial Cancer

Objectives

• Discuss the relevant practice changing results from recent clinical studies for patients with advanced or recurrent endometrial cancer.
• Describe approaches for treatment decision-making based on recent clinical trial results on molecular characterization of endometrial cancer.
• Review the strategies to prioritize and sequence the first-line and second/subsequent-line therapy options recommended in the NCCN Guidelines® for Uterine Neoplasms.

Break

Risk Stratification and Selection of Management Strategy for Localized Prostate Cancer

Objectives

• Identify patient and disease characteristics that should be considered when recommending disease management approaches for patients with localized prostate cancer.
• Discuss strategies to refine risk stratification in appropriate patients with localized prostate cancer.

Updates in the Treatment of Metastatic Urothelial Cancer

Objectives

• Describe new and emerging systemic therapy options for patients with metastatic urothelial bladder cancer and how patient and disease characteristics can guide therapy choice.
• Discuss the results of recent clinical trials for treatment of bladder cancer and their potential impact on treatment.
• Review recent NCCN Guideline updates for the treatment of bladder cancer, and how they may be incorporated into clinical practice.

Management of Renal Cell Carcinoma

Objectives

• Review new and emerging clinical data on immunotherapy options for the treatment of patients with advanced renal cell carcinoma.
• Strategize the selection of first-line and subsequent-line therapies recommended in the NCCN Guidelines® for Kidney Cancer.
• Discuss the relevance and use of immunotherapy in the adjuvant setting for clear-cell renal cell carcinoma.

Registration and Breakfast

Updates in Oncology: Oral Presentations from the NCCN Poster Sessions

Continue the Conversation: Breast Cancer

Team-Based Case Review: Breast Cancer

Objectives

• Identify clinical challenges in managing patients with breast cancer.
• Develop an evidence-based approach for the management of patients with breast cancer.

Improving Infusion Efficiency to Optimize Oncology Care

Objectives

• Discuss the importance of process improvement in infusion clinics.
• Recognize common pitfalls that occur in infusion centers, as well as countermeasures to address those pitfalls.
• Identify strategies that can be used to improve infusion center operations.

Updates to the Management of HR-Positive, HER2-Negative Breast Cancer

Objectives

• Select evidence-based adjuvant treatment options for patients HR-positive and HER2-negative breast cancer based on risk of recurrence.
• Integrate recent advances and available clinical data to optimally select and sequence agents in the treatment of HR-positive and HER2-negative metastatic breast cancer.

Break, Exhibits, and General Poster Session

Variations in Breast Cancer Screening Recommendations

Objectives

• Outline the goals of breast cancer screening.
• Compare and contrast screening recommendations and imaging modalities for breast cancer.